angiotensin ii has been researched along with ruboxistaurin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nakamura, J | 1 |
Bradley, TJ; Cherney, DZ; Lai, V; Reich, HN; Scholey, JW; Slorach, C; Zinman, B | 1 |
1 trial(s) available for angiotensin ii and ruboxistaurin
Article | Year |
---|---|
Systemic hemodynamic function in humans with type 1 diabetes treated with protein kinase Cβ inhibition and renin-angiotensin system blockade: a pilot study.
Topics: Adult; Angiotensin II; Antihypertensive Agents; Blood Glucose; Diabetes Mellitus, Type 1; Enzyme Inhibitors; Female; Glucose Clamp Technique; Hemodynamics; Humans; Hyperglycemia; Indoles; Infusions, Intravenous; Male; Maleimides; Pilot Projects; Protein Kinase C; Protein Kinase C beta; Renin-Angiotensin System | 2012 |
1 other study(ies) available for angiotensin ii and ruboxistaurin
Article | Year |
---|---|
Protein kinase C-dependent antilipolysis by insulin in rat adipocytes.
Topics: Adipocytes; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Androstadienes; Angiotensin II; Animals; Carbazoles; Carcinogens; Dobutamine; Enzyme Activation; Enzyme Inhibitors; Glycerol; Imidazoles; Indoles; Insulin; Isoenzymes; Lipolysis; Male; Maleimides; Protein Kinase C; Rats; Receptor, Insulin; Tetradecanoylphorbol Acetate; Wortmannin | 2007 |